Use of thymidine kinase gene-modified endothelial progenitor cells as a vector targeting angiogenesis in glioma gene therapy

Oncology

Volumn 78, Issue 2, 2010, Pages 94-102

  Zhang, Jun Xia ^a   Kang, Chun Sheng ^c   Shi, Lei ^b   Zhao, Peng ^a   Liu, Ning ^a   You, Yong Ping ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Endothelial progenitor cells; Glioma; Thymidine kinase

Indexed keywords

CASPASE; GANCICLOVIR; LIPOCORTIN 5; PROPIDIUM IODIDE; THYMIDINE KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE TARGETING; GENE THERAPY; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL DIVISION; ENDOTHELIUM, VASCULAR; FETAL BLOOD; GANCICLOVIR; GENE THERAPY; GLIOMA; GLYCOPROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; STEM CELL TRANSPLANTATION; STEM CELLS; THYMIDINE KINASE; TRANSPLANTATION, HETEROLOGOUS; UMBILICAL VEINS;

EID: 77950036473     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000306138     Document Type: Article

References (31)

1. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP: Evidence for circulating bone marrowderived endothelial cells. Blood 1998; 92: 362-367.
2. Dwenger A, Rosenthal F, Machein M, Waller C, Spyridonidis A: Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs. Stem Cells 2004; 22: 86-92.
3. Tamura M, Unno K, Yonezawa S, Hattori K, Nakashima E, Tsukada H, Nakajima M, Oku N: In vivo trafficking of endothelial progenitor cells their possible involvement in the tu mor neovascu larization. Life Sci 2004; 75: 575-584.
4. Ferrari N, Glod J, Lee J, Kobiler D, Fine HA: Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective genetargeting vectors. Gene Ther 2003; 10: 647-656.
5. Moore XL, Lu J, Sun L, Zhu CJ, Tan P, Wong MC: Endothelial progenitor cells' 'homing' specificity to brain tumors. Gene Ther 2004; 11: 811-818.
6. Namba H, Iwadate Y, Kawamura K, Sakiyama S, Tagawa M: Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells. Cancer Gene Ther 2001; 8: 414-420.
7. Asklund T, Appelskog IB, Ammerpohl O, Langmoen IA, Dilber MS, Aints A, Ekstrom TJ, Almqvist PM: Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp Cell Res 2003; 284: 185-195.
8. Huang Q, Pu P, Xia Z, You Y: Exogenous wtp53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells. J Neurooncol 2007; 82: 239-248.
9. Rainov NG: A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 2000; 11: 2389-2401.
10. Trask TW, Trask R P, Aguilar-Cordova E, Shine HD, Wyde PR, Goodman JC, Hamilton WJ, Rojas-Martinez A, Chen SH, Woo SL, Grossman RG: Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther 2000; 1: 195-203.
11. Zhang J, Zhao P, Fu Z, Chen X, Liu N, Lu A, Li R, Sh i L, Pu P, K a ng C, You Y: Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1. Oncol Rep 2008; 20: 1457-1463.
12. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-1201.
13. You Y, Geng X, Zhao P, Fu Z, Wang C, Chao S, Liu N, Lu A, Gardner K, Pu P, Kong C, Ge Y, Judge SI, Li QQ: Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenograf ts. Cel l Mol Life Sci 2007; 6 4: 621-631.
14. Glaser T, Castro MG, Lowenstein PR, Weller M: Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells. Gene Ther 2001; 8: 469-476.
15. Tomicic MT, Thust R, Kaina B: Ganciclovirinduced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation. Oncogene 2002; 21: 2141-2153.
16. Lumniczky K, Safrany G: Cancer gene therapy: combination with radiation therapy and the role of bystander cell killing in the antitumor effect. Pathol Oncol Res 2006; 12: 118-124.
17. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V: Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008; 319: 195-198.
18. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
19. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM: VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972. (Pubitemid 29335849)
20. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schafer B, Hossfeld DK, Fiedler W: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-3112.
21. Jain RK, Duda DG, Clark JW, Loeffler JS: Lessons from phase III clinica l trials on a nti-VEGF therapy for cancer. Nat Clin Pract Oncol 2006; 3: 24-40.
22. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, Stavrou D, Westphal M, Lamszus K: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 2001; 61: 6624-6628.
23. Lamszus K, Kunkel P, Westphal M: Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 2003; 88: 169-177.
24. Barresi V, Belluardo N, Sipione S, Mudo G, Cattaneo E, Condorelli DF: Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther 2003; 10: 396-402.
25. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H: Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004; 11: 1155-1164.
26. Yang SY, Liu H, Zhang JN: Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12. DNA Cell Biol 2004; 23: 381-389.
27. Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H: Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology 2005; 69: 503-508.
28. Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H: Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther 2005; 12: 600-607.
29. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 3307-3318.
30. UhlM, Weiler M, Wick W, Jacobs A H, Weller M, Herrlinger U: Mig ratory neura l stem cel ls for improved thymidine kinase-based gene therapy of malignant gliomas. Biochem Biophys Res Commun 2005; 328: 125-129.
31. Miletic H, Fischer Y, Litwak S, Giroglou T, Waerzeggers Y, Winkeler A, Li H, Himmelreich U, Lange C, Stenzel W, Deckert M, Neumann H, Jacobs AH, von Laer D: Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 2007; 15: 1373-1381.